Wisr Ltd (DirectMoney)

Similar documents
Wisr Ltd (DirectMoney)

Wisr Ltd. New products to underpin growth

Cooks Global Foods Ltd

Noni B (NBL) SFH acquisition could be up to 60% EPS accretive. Key points. Risks and catalysts

Noni B (NBL) BUY: FY18e EBITDA +12.8% Key points. Risks and catalysts

Resetting expectations

Insurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates

Consolidated Operations Group (COG)

MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction. Key points. Risks and catalysts

Tourism Holdings. ROCE exceeds 14% long-term target. Key drivers remain positive. Deeper customer relationships to drive yield

Sealegs Corporation. Sea change. H1 update. Changing business mix. Valuation: New focus improves valuation. H1 results

MEDICAL DEVELOPMENTS INTERNATIONAL LTD

Eddie Stobart Logistics

BUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS

Wisr Limited(DirectMoney)

Praemium (PPS) COMPANY REPORT. Model performance

WINDLAB LTD HOLD. Lakeland financial close delayed again. Downgrade to HOLD. COMPANY UPDATE EVENT IMPACT INVESTMENT VIEW

Centrale del Latte d'italia

Asset revaluation driven by almonds

JackpotJoy plc. A transformational year. Revenue and EBITDA slightly ahead of estimates. Strong operating cash flow dividends from 2019

Praemium (PPS) COMPANY REPORT. Quartermaster

COMPUMEDICS LTD HOLD. CMP Downgrades FY17 Guidance COMPANY UPDATE EVENT KEY TAKE-AWAYS INVESTMENT VIEW

Regional Express Holdings Ltd REX

GB Group. PCA acquisition an excellent fit. PCA adds SME reach to address intelligence services. Earnings enhancing despite growth investment

MNF Group Limited (MNF)

Carr s Group. Diversification continues to give resilience. PBT up for H117 as UK farmers gain in confidence

SomnoMed (SOM) BUY: US channel conflicts abating in Q4. Key points. Risks and catalysts

Centrale del Latte d'italia

Cooks Global Foods. Focused on capital requirements results restated. CGF budgets for 650 stores, targets 800 by 2021

Piteco. Bold entry into the US marketplace. Acquisition of US payments software provider. Forecasts: FY18 revenues rise by 34%, EPS by 12%

Mondo TV. YooHoo! Netflix deal drives significant upgrades. Global deal with Netflix, new Chinese productions. Significant increase to five-year plan

Centrale del Latte d'italia

INDEPENDENT ACCOUNTANT S REPORT REVIEW OF PROSPECTIVE FINANCIAL INFORMATION

Evolva. EverSweet. Delivering on the new strategy. FY17 results. Valuation: Fair value of CHF0.60 per share. FY17 results.

DICKER DATA LIMITED ANNUAL RESULTS

Circle Property. Lifting estimates again. Revaluation gains and strong rent growth. Upside potential from refurbished assets

Financial Services Guide

Helma Eigenheimbau. Scale research report - Update. Market bottlenecks limiting momentum. H117 results showing moderate growth

CREDIBLE LABS INC BUY. Partnership Marketing Strategy Paying Off EVENT COMPANY UPDATE HIGHLIGHTS INVESTMENT VIEW. Q4 Activities Report.

Noni B (NBL) BUY: Acquisition may signal the end of discounting in mature womenswear. Key points. Risks and catalysts

Genex Power (GNX) COMPANY REPORT. NAIF lined up for Stage 2

24 November Financial Services Guide

ONEVIEW HEALTHCARE PLC

TXT e-solutions. Strong cash flow supports dividend boost. PACE acquisition boosts FY16 performance. Minor changes to earnings forecasts

Suncorp Financial Services Pty Ltd

Paysafe Group. Growth normalises. Growth moderates in H117. Pro forma financials show potential impact of deals

PRICE $1.16 Regional Express Holdings Ltd REX

SomnoMed (SOM) An eye on RSS channel conflict but the core offering to prevail in US direct market. Key points. Risks and catalysts

K3 Business Technology

Platinum Asset Management (PTM)

PRICE $1.30 Regional Express Holdings Ltd REX

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation

AtCor Medical Holdings Limited (ACG)

International Stem Cell

Shanks Group. Global commodity crisis offsetting progress. Netherlands Commercial progress encouraging

Freedom Insurance (FIG)

Slater & Gordon Limited

INDEPTH RESEARCH NOTE Brambles Ltd Buy

Codan Limited (ASX: CDA)

Zip Co. Improved medium term cost guidance. Last Price A$0.96 Target Price A$1.00 (Previously A$0.90) Recommendation Accumulate Risk Higher

XP Power. Strong demand drives record performance in H1. H118 sees continuation of strong growth

Nanosonics Limited. Australia Health Care Equipment & Supplies. Growth outlook unchanged. Earnings Forecasts. Source Company, LINWAR Research

Auckland International Airport

Gear4music Holdings. Market share gains and margin boost. Strong pre-christmas trading. FY18 forecast maintained

Nanosonics (NAN) 1H17: Cash earnings beat grabs attention. Key points

APN Outdoor Group (APO)

Perpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions

Financial Services Guide. Terms & Conditions. and. 20 March Connected Services

Carclo. Contract delays to affect H218 performance. Delayed placement of contracts by customers. Non-medical demand lower than forecast.

The Quarto Group. Good visibility into H2. Building on strengths. Group in improving shape for CFO transition. Valuation: Discount remains substantial

YOUR TAGLINE HERE. FINANCIAL SERVICES GUIDE EP FINANCIAL SERVICES ABN AFSL

GLG Life Tech. Luo Han Guo drives revenue growth. Tate & Lyle LHG contract boosts top line. H3 and H4 leaf should improve stevia margins

Financial Services Guide Suncorp Everyday Super

Regional REIT. Retail eligible bond 4.5% Regional markets have remained robust. Retail eligible bond offering. Launch of bond issue.

Pacific Energy (PEA)

FINANCIAL SERVICES GUIDE. Third Party Platform Pty Ltd (ABN ) AFSL No Participant of the ASX Group WHO ARE WE?

OANDA Australia Pty Ltd

TXT e-solutions. Steady growth in Q3. Growth for both businesses in Q3. Outlook and changes to forecasts

Zip Co. Delivering against expectations. Last Price A$0.86 Target Price A$0.90 (Previously A$0.88) Recommendation Accumulate Risk Higher.

FINANCIAL SERVICES GUIDE CROWDFUNDING AFSL PTY LTD

2011 Interim Results. Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer

OneVue Holdings (OVH)

KEFI Minerals. Counting down to production. Outstanding matters. Valuation: 6.55p/sh in FY18 rising to 7.21p/sh in FY19.

FINANCIAL SERVICES GUIDE

Monitise. FY14 growth on track. Focus on expanding the network. Guidance maintained for FY14. Valuation: Reflects growth potential.

OneVue Holdings (OVH)

Financial Services Guide

Vista Group International

Financial Services Guide

Quixant. A very promising year ahead. Volume deliveries to new major customers. Current order book over double the prior year

Financial Services Guide

artnet For art's sake FY15: Art fair partnerships and forays to China Intended reporting change Valuation: Overshadowed Q1 figures

Financial Services Guide

For personal use only

Ceres Power Holdings. Progressing towards commercialisation. Progressing the technology. Securing routes to market

For personal use only

Cooks Global Foods. Funded for growth. Growth plans. Interim results. Valuation: Upside in valuation. Interim results.

OTC Markets Group. Record quarterly revenues. Q115 Corporate services revenue rises 54% Operating expenses rise 18% in Q115.

TerraNet Holding. Irons in the fire. Five new strategic development orders won in Q317. Cash flow burn reflecting multi-project activity

Financial Service Guide GMTK Global Pty Limited

Transcription:

Wisr Ltd (DirectMoney) Interim result draws a line in the sand Wisr Limited (WZR.AX) is an online consumer lending platform competing in the rapidly growing marketplace-lending sector. The company has undergone significant transformation in the past 18 months, including a name change from DirectMoney (DM1.AX) (which shareholders approved on February 28) and a restructure of its management team, board and business model. Wisr reported H118 revenues of $0.76m, up 34% on pcp and a net loss of $3.1m, up 12% on prior. Our DCF valuation remains at $60m or $0.13/share and is supported by several other valuation methodologies. Please refer to our 26-page positioning paper published on 5 February and available at www.raasgroup.com for further detail on our valuation. Interim result The company reported H118 revenue of $0.76m up 34% on the prior year and a net loss of $3.1m, up from $2.8m a year before. Revenues were below our forecast for $0.81m for the half and this had a flow on effect to the net loss. Our forecast was for a net operating loss for the half of $2.5m. Expenses in the period increased 16%, predominantly due to an increase in employee expenses and marketing spend. Marketing spend of $0.97m was up from $0.14m y-o-y and was the main contributor to the 63% increase in other expenses. Employee costs of $1.8m, which included non-cash share based payments of $0.13m, increased 24% and reflects the company s investment in head count for its next growth phase. DM1 noted that it expected similar staff costs in H218. The operating cash loss for the period was $1.48m, up from $1.1m on pcp. At period end, Wisr had $1.85m cash in hand. The result reflects a period of restructure for the company and, in our view, marks a line in the sand for the company s future performance. Earnings adjustments and valuation We have adjusted our forecasts for FY18 following the interim result and are now forecasting revenues of $1.85m, down from $1.9m previously, and a net loss of $4.75m, down from $3.55m previously. Our forecasts for FY19 and beyond are unchanged. We continue to anticipate that the company will be cashflow breakeven in 2H19 and profitable in FY20. Our base case forecasts are predicated on WZR following a similar growth trajectory to its Australian and international peers. This underpins our DCF valuation of $0.13/share which is further supported by several other methodologies including loan book valuation, and early stage valuations. In our view, execution of its strategy over the next 12-24 months should see WZR increase its loan book to ~$85m by the end of FY19 and this in turn should help reduce the gap between its current market capitalisation and our DCF valuation of $0.13/share. Historical earnings and RaaS Advisory estimates Year Revenue EBITDA reported NPAT reported EPS* P/E end (c) (x) 06/17 1.16-5.35-5.43-1.78 n/a 06/18e 1.85-5.37-4.75-1.08 n/a 06/19e 6.73-0.37-0.43-0.09 n/a 06/20e 14.16 5.6 3.8 0.85 3.8 Source: WZR data, RaaS Advisory Estimates for FY18e, FY19e and FY20e Share details ASX Code 2 March 2018 WZR/DM1 Share price (at 1 March) $0.032 Market Capitalisation $17.6M Shares on issue 455.5M Net cash at 31 Dec 2017 Share performance (12 months) $0.07 $0.06 $0.05 $0.04 $0.03 $0.02 $0.01 $- Upside Case Board and management team experienced in building financial services businesses Has secured the backing of 255 Finance in a wholesale funding agreement and shares/options agreement Opportunity to be a part of likely industry consolidation Downside Case Very small player in a segment of less than 1% of the personal lending market Competitors have aggressively grabbed market share over the past two years Stock liquidity, free float less than 40% Board of Directors John Nantes Craig Swanger Chris Whitehead Company contacts Anthony Nantes CEO $1.85M Chairman Non-Executive Director Non-Executive Director +61 401 995 037 a.nantes@wisr.com.au www.wisr.com.au/www.directmoney.com.au RaaS Advisory contacts Finola Burke +61 414 354 712 finola.burke@raasgroup.com Moira Daw +61 418 697 275 moira.daw@raasgroup.com This report has been prepared by RaaS Advisory Pty Ltd (A.C.N. 614 783 363) on behalf of Wisr Ltd and should be read in conjunction with the disclaimer and Financial Services Guide at the end of the report.

Wisr Limited (WZR) Share price (1 March 2018]) A$ 0.032 Profit and Loss Interim H117A H217A H118F H218F H119F H219F Y/E 30 June FY16A FY17A FY18F FY19F FY20F Revenue 0.6 0.6 0.8 1.1 2.7 4.0 EBITDA - 2.7-3.0-3.1-2.3-0.8 0.4 EBIT - 2.7-3.0-3.1-2.3-0.8 0.4 Revenue 1.2 1.2 1.8 6.7 14.2 NPAT (normalised) - 2.8-3.0-3.1-1.7-0.7 0.2 EBITDA (6.0) (5.3) (5.4) (0.4) 5.6 Minorities - - - - - - Depn (0.0) (0.0) (0.0) (0.0) (0.0) NPAT (reported) - 2.8-3.0-3.1-1.7-0.7 0.2 Amort 0.0 0.0 0.0 0.0 0.0 EPS (normalised) - 0.81-0.77-0.71-0.37-0.14 0.05 EBIT (8.7) (5.4) (5.4) (0.4) 5.6 EPS (reported) - 0.81-0.70-0.71-0.37-0.14 0.05 Interest (0.1) (0.1) (0.0) (0.2) (0.3) Dividend (cps) - - - - - - Tax 0.0 0.0 0.6 0.2 (1.5) Imputation 28.0 28.0 28.0 28.0 28.0 28.0 Minorities 0.0 0.0 0.0 0.0 0.0 Operating cash flow - 1.1-1.6-1.5-3.5-1.1-0.1 Equity accounted assoc 0.0 0.0 0.0 0.0 0.0 Free Cash flow - 1.1-1.6-1.5-3.4-1.0-0.0 NPAT pre significant items (8.8) (5.4) (4.7) (0.4) 3.9 Divisions H117A H217A H118F H218F H119F H219F Significant items 0.0 0.0 0.0 0.0 0.0 Rev - Establishment fees 0.5 0.4 0.5 0.5 1.4 2.1 NPAT (reported) (8.8) (5.4) (4.7) (0.4) 3.9 Rev - Margin - - - 0.2 0.7 1.1 Cash flow Rev - Referral Fees - - - 0.1 0.3 0.6 Y/E 30 June FY16A FY17A FY18F FY19F FY20F Rev - Other revenue 0.1 0.2 0.2 0.3 0.3 0.3 EBITDA (6.0) (5.3) (5.4) (0.4) 5.6 Interest (0.1) (0.0) 0.0 (0.2) (0.3) Costs - Salaries - 1.6-2.7-1.8-1.5-1.5-1.6 Tax 0.0 0.0 0.0 (0.1) (1.5) Costs - Marketing - 0.1-0.5-1.0-0.5-0.5-0.5 Working capital changes (2.6) 2.6 0.4 (0.5) (0.8) Costs - Prov for bad debts - 0.2-0.2 0.0-0.1-0.1-0.2 Operating cash flow (8.7) (2.7) (5.0) (1.2) 3.1 Costs - Other costs - 1.4-0.1-1.0-1.3-1.3-1.3 Mtce capex 0.0 (0.1) (0.0) (0.0) (0.0) Free cash flow (8.7) (2.8) (5.0) (1.2) 3.1 EBITDA - 2.7-2.9-3.1-2.3-0.8 0.4 Growth capex 0.0 0.0 (0.1) (0.1) (0.1) Acquisitions/Disposals (0.5) 0.0 0.0 0.0 0.0 Margins, Leverage, Returns FY16A FY17A FY18F FY19F FY20F Other 0.0 0.0 0.0 0.0 0.0 EBITDA -482.5% -460.9% -290.4% -5.5% 39.7% Cash flow pre financing (9.2) (2.8) (5.0) (1.3) 3.0 EBIT -701.7% -461.9% -291.1% -5.7% 39.6% Equity 11.3 5.4 0.6 0.0 0.0 NPAT pre significant items -707.8% -468.2% -256.9% -6.4% 27.2% Debt (1.0) (0.4) (0.1) 0.0 0.0 Net Debt (Cash) 0.3 2.8-5.1-11.3-18.6 Dividends paid 0.0 0.0 0.0 0.0 0.0 Net debt/ebitda (x) (x) n/a n/a n/a n/a - 3.314 Net cash flow for year 1.1 2.2 (4.6) (1.3) 3.0 ND/ND+Equity (% ) (% ) -3.5% -43.9% 48.1% 69.1% 67.7% Balance sheet EBIT interest cover (x) (x) n/a n/a n/a n/a 0.0 Y/E 30 June FY16A FY17A FY18F FY19F FY20F ROA -88.8% -52.0% -45.9% -2.5% 23.4% Cash 1.3 3.5 1.9 1.9 1.9 ROE -111% -64% -65% -8% 55% Accounts receivable 0.1 0.1 0.2 0.7 1.5 ROIC -228% -148% -108% -5% 30% Inventory 0.0 0.0 0.0 0.0 0.0 NTA (per share) 0.03 0.02 0.01 0.01 0.02 Other current assets 1.8 2.0 3.5 8.7 16.6 Working capital - 0.7-0.7 0.2 0.7 1.5 Total current assets 3.2 5.6 5.5 11.3 20.0 WC/Sales (%) -54% -62% 11% 11% 11% PPE 0.0 0.1 0.1 0.2 0.3 Revenue growth -6% 59% 264% 110% Goodwill 0.0 0.0 0.0 0.0 0.0 EBIT growth pa n/a n/a n/a n/a -1556% Investments 0.5 0.5 0.5 0.5 0.5 Pricing FY16A FY17A FY18F FY19F FY20F Deferred tax asset 0.0 0.0 0.6 0.9 0.9 No of shares (y/e) (m) 272 437 455 455 455 Loan receivables 6.0 4.7 5.8 5.5 7.9 Weighted Av Dil Shares (m) 269 396 452 455 455 Total non current assets 6.6 5.3 7.1 7.1 9.6 Total Assets 9.8 10.8 12.6 18.4 29.6 EPS Reported cps - 3.94-1.71-1.05-0.09 0.83 Accounts payable 0.8 0.8 0.0 0.0 0.0 EPS Normalised/Diluted cps - 3.99-1.58-1.08-0.09 0.85 Short term debt 1.0 0.7 5.3 11.9 16.8 EPS growth (norm/dil) n/a n/a n/a n/a -996% Tax payable 0.0 0.0 0.0 0.0 0.0 DPS cps - - - - - Other current liabilities 0.1 0.2 0.2 0.2 0.2 DPS Growth n/a n/a n/a n/a n/a Total current liabilities 1.9 1.6 5.5 12.0 16.9 Dividend yield 0.0% 0.0% 0.0% 0.0% 0.0% Long term debt 0.0 0.0 1.6 1.3 3.7 Dividend imputation 28 28 28 28 28 Other non current liabs 0.0 0.0 0.0 0.0 0.0 PE (x) - - - - 3.8 Total long term liabilities 0.0 0.0 1.6 1.3 3.7 PE market 15.2 15.2 15.2 Total Liabilities 1.9 1.6 7.1 13.3 20.7 Premium/(discount) -100% -75% Net Assets 7.9 9.2 5.5 5.1 8.9 EV/EBITDA - 1.4-2.1-3.7-69.5 5.9 FCF/Share cps -3.2-0.6-1.1-0.3 0.7 Share capital 22.4 28.6 29.3 29.3 29.3 Price/FCF share - 1-5 - 3-12 4.7 Accumulated profits/losses (15.4) (20.8) (25.5) (26.0) (22.1) Free Cash flow Yield -99.6% -19.1% -34.0% -8.1% 21.3% Reserves 0.8 1.4 1.8 1.8 1.8 Minorities 0.0 0.0 0.0 0.0 0.0 Total Shareholder funds 7.9 9.2 5.5 5.1 8.9 Source: RaaS Advisory

FINANCIAL SERVICES GUIDE RaaS Advisory Pty Ltd ABN 99 614 783 363 Corporate Authorised Representative, number 1248415 of BR SECURITIES AUSTRALIA PTY LTD ABN 92 168 734 530 AFSL 456663 Effective Date: 11 th May 2017

About Us BR Securities Australia Pty Ltd (BR) is the holder of Australian Financial Services License ( AFSL ) number 456663. RaaS Advisory Pty Ltd (RaaS) is an Authorised Representative (number 1248415) of BR. This Financial Service Guide (FSG) is designed to assist you in deciding whether to use RaaS s services and includes such things as - who we are - our services - how we transact with you - how we are paid, and - complaint processes Contact Details, BR and RaaS BR Head Office: Level 2, 129 Robertson Street, Fortitude Valley QLD, 4006 RaaS. 20 Halls Road Arcadia, NSW 2159 P: +61 414 354712 E: finola.burke@raasgroup.com RaaS is the entity providing the authorised AFSL services to you as a retail or wholesale client. What Financial Services are we authorised to provide? RaaS is authorised to - provide general advice to retail and wholesale clients in relation to - Securities - deal on behalf of retail and wholesale clients in relation to - Securities The distribution of this FSG by RaaS is authorized by BR. Our general advice service Please note that any advice given by RaaS is general advice, as the information or advice given will not take into account your particular objectives, financial situation or needs. You should, before acting on the advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Prospectus, Product Disclosure Statement or like instrument. As we only provide general advice we will not be providing a Statement of Advice. We will provide you with recommendations on securities Our dealing service RaaS can arrange for you to invest in securities by firstly sending you the offer document and then assisting you fill out the application from if needed. How are we paid? RaaS earns a fee from companies for providing a research report and/or a financial model on the company, for dealing in its securities or for assisting in raising capital. You don t pay anything. Associations and Relationships BR, RaaS, its directors and related parties have no associations or relationships with any product issuers other than when advising retail clients to invest in managed funds when the managers of these funds may also be clients of BR. RaaS s representatives may from time to time deal in or otherwise have a financial interest in financial products recommended to you but any material ownership will be disclosed to you when relevant advice is provided. Complaints If you have a complaint about our service you should contact your Adviser and tell them about your complaint, the adviser will follow our internal dispute resolution policy, including sending you a copy of the policy if required BR is a member of the Financial Ombudsman Service, our external dispute resolution provider. Financial Ombudsman Service GPO Box 3 Melbourne VIC 3001 Telephone: 1300 78 08 08 Email: nfo@fos.org.au Professional Indemnity Insurance BR has in place Professional Indemnity Insurance which satisfies the requirements for compensation under s912b of the Corporations Act and that covers our authorized representatives.

DISCLAIMER and DISCLOSURES This report has been commissioned by Wisr/DirectMoney Ltd and prepared and issued by RaaS Advisory Pty Ltd. RaaS Advisory received a fee for preparation of this report. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however neither DirectMoney Ltd nor RaaS Advisory guarantee the accuracy or completeness of this report. Opinions contained in this report represent those of the principals of RaaS Advisory at the time of publication. This research is issued in Australia by RaaS Advisory and any access to it should be read in conjunction with the Financial Services Guide on the previous two pages. RaaS Advisory holds Corporate Authorised Representative no 1248415 of AFSL 456663. This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. This document is provided for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. Past performance is not a guarantee of future performance. To the maximum extent permitted by law, RaaS Advisory, its affiliates, the respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. Copyright 2018 RaaS Advisory Pty Ltd (A.B.N. 99 614 783 363). All rights reserved.